<DOC>
	<DOCNO>NCT02610933</DOCNO>
	<brief_summary>This study examine patient chronic hemodialysis non-valvular atrial fibrillation , CHA2DS2-VASc Score ≥ 2 therefore candidate already receive vitamin K antagonist . The first question whether replacement vitamin K antagonist rivaroxaban able slow progression vascular calcification . The second question whether addition vitamin K2 rivaroxaban slow even halt progression vascular calcification .</brief_summary>
	<brief_title>Effect Vascular Calcification Replacing Warfarin Rivaroxaban With Without VitK2 Hemodialysis Patients</brief_title>
	<detailed_description>The present study target dialysis patient non-valvular atrial fibrillation require treatment vitamin K antagonists . It address question whether replacement vitamin K antagonist rivaroxaban able slow progression vascular calcification ( VC ) . The second research question whether addition vitamin K2 rivaroxaban beneficially affect progression VC . Two non-invasive method use evaluate impact intervention progression VC : i.e . coronary artery calcification ( CAC ) pulse wave velocity ( PWV ) measurement . The detection CAC predictive presence obstructive coronary artery disease future coronary event . VC stiffen central elastic-type artery independent predictor cardiovascular morbidity mortality hemodialysis patient .</detailed_description>
	<mesh_term>Calcinosis</mesh_term>
	<mesh_term>Vascular Calcification</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin K</mesh_term>
	<mesh_term>Vitamin K 2</mesh_term>
	<mesh_term>Vitamin MK 7</mesh_term>
	<mesh_term>Rivaroxaban</mesh_term>
	<criteria>end stage renal failure treat chronic hemodialysis atrial fibrillation CHA2DS2VASc Score ≥ 2 ability provide inform consent know intestinal malabsorption inability take oral medication inability stop comedication cause major interaction rivaroxaban ( e.g . ketoconazole , itraconazole , voriconazole , posaconazole , ritonavir , rifampicin , phenytoin , carbamazepine , phenobarbital St John 's wort ) investigator 's assessment subject 's life expectancy le 1 year prosthetic mechanical heart valve contraindication anticoagulation liver dysfunction ChildPugh grade BC pregnancy , breastfeeding , inadequate contraception incompliance medication schedule investigation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>vascular calcification</keyword>
	<keyword>hemodialysis</keyword>
	<keyword>rivaroxaban</keyword>
	<keyword>vitamin K2</keyword>
</DOC>